查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1467967

人类增强市场：按类型、功能、最终用途划分 - 2024-2030 年全球预测

Human Augmentation Market by Type (Augmented Reality Device, Biometric System, Exoskeletons), Functionality (Body Worn, Non-Body Worn), End-use - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年人类增强市场规模为2,558.4亿美元，2024年将达2,962.4亿美元，2030年将达7,214.4亿美元，复合年增长率为15.96%。

人类增强涉及使用科技和各种手段来提高人体和心灵的能力和特征。它涉及整合技术设备、植入和矫正器具等外部组件，以增强人类功能并超越人类的自然能力。人类增强技术包括身体增强、认知增强、感官增强和生物骇客等多种应用。提高认知和身体增强应用的意识和接受度是市场成长的催化剂。人类增强技术在军事领域的不断应用，以增强士兵的身体和认知能力，正在推动市场成长。由于缺乏有关人类增强技术的使用和应用的通用标准和指南，市场成长受到阻碍。此外，人类增强技术的研究、开发和最终应用相关的高成本正在阻碍市场成长。市场供应商在机器人、人工智慧和生物技术等领域的快速开拓将有助于创建更先进、更有效的人类增强设备和解决方案。预计这些将为市场成长创造机会。

主要市场统计
基准年[2023] 2558.4亿美元
预测年份 [2024] 2962.4亿美元
预测年份 [2030] 7214.4亿美元
复合年增长率（%） 15.96%

扩大扩增实境设备的使用，以提供免持资料存取和导航指导

扩增实境(AR) 设备是可穿戴技术，可将数位资讯或虚拟物件迭加到实体世界上。它满足了改善用户体验和生产力的需求。这些设备的需求量很大，因为它们可以提供免持资料存取和导航指导。指纹/虹膜扫描器和脸部辨识系统等生物辨识技术用于身份验证和识别，因其便利性和安全性而受到青睐。生物辨识系统是一种根据生理或行为特征验证或确定活人身分的自动化方法。外骨骼是与人类能力互动的可穿戴移动机器。外骨骼附着在躯干或四肢上，并使用动力关节和连桿来增加力量和耐力。外骨骼通常用于帮助人类移动并促进体力任务。智慧虚拟助理 (IVA) 是能够理解语音命令和自然语言以协助人类完成各种任务的软体代理。 IVA 嵌入到各种连网设备和平台中，方便、免持地扩展人类能力。虚拟实境 (VR) 设备将使用者带入身临其境型电脑生成的环境中。 VR 可用于游戏、娱乐、教育、训练、模拟等。 VR 提供的高度沉浸式体验扩展了人类的感知、认知和身体能力。穿戴式装置被整合到服装和配件中以增强功能。更先进的穿戴式装置可以提供扩增实境显示，追踪眼球运动和大脑活动，并增强人类的体力和耐力。

功能：更多使用穿戴式人体人类增强来增强活动能力和耐力

穿戴式人类增强包括物理连接到身体并增强身体能力的设备，例如外骨骼、穿戴式健康监视器和义肢。这些穿戴式装置通常用于製造和医疗保健产业，以增强个人的力量、运动表现和耐力。非穿戴式人类增强包括专注于认知或感官增强的设备，包括无需物理附着即可提供功能增强的神经技术和可植入设备。这些技术不需要对身体进行物理附着，并且通常专注于认知或感官增强。

最终用户：透过扩大人类增强技术在製造业的应用来提高工人的生产力和效率

在航太和国防领域，人类增强技术用于增强身体和认知能力，以确保卓越的性能和安全性。人类增强外装或外骨骼可以增强士兵的体力和耐力，减少长途任务期间的疲劳，并提高机动性。在医疗保健领域，人类增强技术在復健、患者照护和改善残障人士的生活品质方面发挥着重要作用。矫正器具人类增强义肢可提高截肢者的活动能力和生活品质。穿戴式监视器和健康追踪设备支援慢性病管理，并向患者和医疗保健提供者提供即时健康资料。人类增强技术对于提高製造业工人的生产力、安全性和效率至关重要。外骨骼穿戴式装置减轻了工人的身体压力，特别是在涉及手动或重复性任务的行业中。人类增强技术在媒体和娱乐领域提供沉浸式体验和创造性可能性。这些技术可实现身临其境型游戏、互动故事叙述以及丰富主题乐园和娱乐场所的体验。

区域洞察

美洲人类增强市场在很大程度上是一个新兴市场，因为本土企业专注于机器人、人工智慧和扩增实境的不断进步。北美，特别是美国，是主要贡献者，增加了对外骨骼、神经控制介面以及义肢和矫正器具技术的投资。该地区对医疗保健、军事和工业领域人类赋权的关注正在推动市场扩张。由于该地区医疗保健和製造业的扩张，亚太地区人类增强市场正在显着成长。日本和韩国等国家在开髮用于医疗保健和老年护理应用的机器人外骨骼和穿戴式装置方面处于领先地位。亚太地区市场的特点是应用多样化，包括医疗设备和工业外骨骼，反映出人类增强技术的广泛采用。正在进行的仿生眼研究和欧盟委员会的大量资助正在推动人们对人类增强的兴趣，并且是欧洲市场成长的基础。由于对仿生义肢以及医疗保健和復健辅助技术的投资，中东和非洲地区的人类增强市场正在成长。多样化的应用，加上该地区的研发工作，正在为欧洲、中东和非洲地区人类增强市场的扩张做出贡献。

FPNV定位矩阵

FPNV 定位矩阵对于评估人类增强市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对人类增强市场中供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，以获得市场竞争优势。

本报告在以下方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4. 竞争评估和情报：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.人类增强市场的市场规模和预测是多少？

2.在人类增强市场的预测期内，有哪些产品、细分市场、应用程式和领域需要考虑投资？

3.人类增强市场的技术趋势和法规结构是什么？

4.人类增强市场主要厂商的市场占有率为何？

5. 进入人类增强市场的合适型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 提高人们对可增强认知和身体表现的应用程式的认识和接受度
      • 医疗穿戴式装置对人类增强的需求不断增长
      • 航太和国防领域对手势追踪的需求不断增长
    • 抑制因素
      • 开发人类增强技术的成本很高。
    • 机会
      • 继续介绍技术先进的人类增强
      • 政府对技术开发的支持与私人投资
    • 任务
      • 由于使用人类增强技术而存在资料和个人资讯外洩的风险
  • 市场区隔分析
    • 类型：扩大扩增实境设备的使用，提供免持资料存取和导航指导
    • 功能：更多使用穿戴式人体人类增强来提高活动能力和耐力
    • 最终用户：扩大人类增强技术在製造业的应用，以提高工人的生产力和效率
  • 市场趋势分析
    • 美洲军事和国防领域更多采用人类增强产品
    • 专注于亚太地区突破性人类增强技术的研发
    • 大力投资开发创新人类增强技术并扩大欧洲、中东和非洲地区在航太和国防领域的应用
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法规结构分析

第六章人类增强市场：依类型

  • 扩增实境设备
  • 生物识别系统
  • 外骨骼
  • 智慧虚拟助理
  • 虚拟实境设备
  • 穿戴式装置

第七章依功能分類的人类增强市场

  • 身体穿着
  • 非身体佩戴的

第八章人类增强市场：依最终用途分类

  • 航太和国防
  • 卫生保健
  • 製造业
  • 媒体和娱乐

第九章北美和南美的人类增强市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太地区人类增强市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲的人类增强市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争场景分析
    • Google和高通合作开发用于穿戴式装置的 RISC-V 晶片
    • Vuzix 与广达电脑签署合作协议
    • Humane正式推出基于OpenAI的可穿戴设备“AI Pin”
    • 实现人与人之间的连结：Phantom Neuro 结合了人类增强和物联网
    • 由 SFU 研究人员开发的 XoMotion 成为世界上最先进的外骨骼，适用于行动不便的人
    • 杜邦与意法半导体 (ST) 合作开发用于监测生物讯号的新型智慧穿戴装置概念
    • 穿戴式装置公司 Oura 收购数位身分Start-UpsProxy
    • 200 万欧元资金用于新型人类增强创新，以增强人类的防御能力
    • ARIA Research 获得 140 万美元津贴，在雪梨建立人类增强研究所
    • Ekso Bionics 宣布从 Parker Hannifin 公司收购人体运动与控制业务部门，包括 Indego 产品线
    • 京瓷在日本推出新的人类增强技术原型，配备先进的人工智慧以增强人类能力
    • Dasa 推出新的创新重点领域：人类增强(HA)
    • 巴黎Start-Ups筹集 4500 万美元用于开发人类体外骨骼

第13章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-0355904475EC

[185 Pages Report] The Human Augmentation Market size was estimated at USD 255.84 billion in 2023 and expected to reach USD 296.24 billion in 2024, at a CAGR 15.96% to reach USD 721.44 billion by 2030.

Human augmentation includes using technology and various means to improve the capabilities and attributes of the human body and mind. It involves integrating external components, such as technological devices, implants, and prosthetics, to enhance human functions, extending beyond natural human capabilities. Human augmentation technologies encompass various applications, including physical enhancements, cognitive improvements, sensory augmentations, and biohacking. Growing awareness and acceptance of cognitive and physical enhancement applications serve as catalysts for market growth. Expanding the application of human augmentation technologies in the military to enhance soldiers' physical and cognitive capabilities is driving market growth. The lack of universal standards and guidelines regarding using and applying human augmentation technologies hampers market growth. Additionally, high costs associated with research, development, and the eventual application of human augmentation technologies impede market growth. Rapid developments in fields such as robotics, artificial intelligence, and biotechnology by market vendors enable the creation of more advanced and effective human augmentation devices and solutions. They are expected to create opportunities for market growth.

KEY MARKET STATISTICS
Base Year [2023] USD 255.84 billion
Estimated Year [2024] USD 296.24 billion
Forecast Year [2030] USD 721.44 billion
CAGR (%) 15.96%

Type: Expanding usage of augmented reality devices to provide hands-free data access and navigation guidance

Augmented reality (AR) devices are wearable technologies that overlay digital information and virtual objects in the physical world. They meet the need for enhanced user experiences and productivity. These devices are in high demand due to their ability to provide hands-free data access and navigation guidance. Biometric technologies such as fingerprint/iris scanners and facial recognition systems are used for authentication and identification and are preferred for convenience and security. Biometric systems are automated methods for verifying or specifying the identity of a living person based on a physiological or behavioral characteristic. Exoskeletons are wearable mobile machines that work in conjunction with human capabilities. They fit around the torso and limbs and use powered joints and links to increase strength and endurance. Exoskeletons are often used to aid human mobility and make physical tasks easier. Intelligent virtual assistants (IVAs) are software agents that understand voice commands and natural language to assist humans with various tasks. IVAs are integrated into various internet-connected devices and platforms to augment human capabilities conveniently and hands-freely. Virtual reality (VR) devices transport users into an immersive computer-generated environment. VR is used for gaming, entertainment, education, training, and simulation. The highly immersive experience offered through VR augments human perception, cognition, and physical capabilities. Wearable devices are integrated into clothing or accessories items to enhance capabilities. More advanced wearables could provide augmented reality displays, track eye movements and brain activity, and enhance human physical strength or endurance.

Functionality: Increasing usage of body-worn human augmentation to enhance mobility and endurance

Body-worn human augmentation involves devices physically attached to the body, such as exoskeletons, wearable health monitors, and prosthetics, enhancing physical abilities. These body-worn human devices are often used in manufacturing and healthcare industries to enhance strength, mobility, and endurance of individuals. Non-body-worn human augmentation includes devices, including neurotechnology and implantable devices that provide enhancements without physical attachment, focusing on cognitive or sensory augmentation. These technologies do not require physical attachment to the body and are often focused on cognitive or sensory augmentation.

End-user: Increasing application of human augmentation technologies in the manufacturing sector to improve worker productivity and efficiency

In the aerospace & defense sector, human augmentation technologies are employed to enhance physical and cognitive abilities, ensuring superior performance and safety. Exosuits and exoskeletons human augmentation devices augment soldiers' physical strength and endurance, reducing fatigue during long missions and providing enhanced mobility. In healthcare, human augmentation technologies play a crucial role in rehabilitation, patient care, and improving the quality of life of individuals with disabilities. Prosthetic human augmentation enhances mobility and quality of life for amputees. Wearable monitors and health-tracking devices assist in managing chronic conditions and provide real-time health data for patients and healthcare providers. Human augmentation technologies are integral in the manufacturing sector to improve worker productivity, safety, and efficiency. Exoskeletons wearable devices reduce the physical strain on workers, particularly in industries involving heavy lifting or repetitive tasks. Human augmentation technologies offer immersive experiences and creative possibilities in the media & entertainment sector. These technologies enable immersive gaming, interactive storytelling, and enhanced experiences in theme parks and entertainment venues.

Regional Insights

The human augmentation market in the Americas represents a highly developing landscape due to the presence of native market players focusing on continuous advancements in robotics, artificial intelligence, and augmented reality. North America, particularly the United States, has been a key contributor, with increasing investments in exoskeletons, neural control interfaces, and prosthetic technologies. The region's focus on enhancing human capabilities in healthcare, military, and industrial sectors has spurred market expansion. The APAC human augmentation market has witnessed notable growth due to the region's expanding healthcare and manufacturing sectors. Countries such as Japan and South Korea have been at the forefront of developing robotic exoskeletons and wearable devices for healthcare and elderly care applications. APAC region's market is characterized by diverse applications, including medical devices and industrial exoskeletons, reflecting the wide adoption of human augmentation technologies. Ongoing research in bionic eye installations and considerable funding support from the European Commission underlined the growing interest in human augmentation, creating a platform for market growth in Europe. The Middle East and Africa regions human augmentation market is growing with investments in bionic limbs and assistive technologies for healthcare and rehabilitation. The diverse range of applications, coupled with the region's commitment to research and development, has contributed to expanding the human augmentation market throughout EMEA.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Human Augmentation Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Human Augmentation Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Human Augmentation Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Amazon.com, Inc., Apple Inc., AppliedVR, Inc., Aptima, Inc., Atheer, Inc., B-Temia Inc., Charles River Analytics, Inc., Cionic, Inc., Cognitive Mill by AIHunters, Continental AG, CYBERDYNE Inc., Ekso Bionics Holdings, Inc., Esper Bionics Inc., Fujitsu Limited, Garmin Limited, General Motors Company, Google LLC by Alphabet, Inc., HID Global Corporation by Assa Abloy AB, Hocoma AG by DIH International Limited, HTC Corporation, Hyundai Motor Company, IDEMIA Group, S.A.S., Kyocera Corporation, Lifesense Group, Magic Leap Inc., Meta Platforms, Inc., Microsoft Corporation, NEC Corporation, Nvidia Corporation, Ottobock SE & Co. KGaA, Panasonic Corporation, Parker Hannifin Corporation, Rewalk Robotics Inc., Rex Bionics Ltd, Robert Bosch GmbH, RTX Corporation, Saab AB, Samsung Electronics Co., Ltd., Soar Technology, Inc., Sony Group Corporation, Thales Group, Unity Software Inc., and Vuzix Corporation.

Market Segmentation & Coverage

This research report categorizes the Human Augmentation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Augmented Reality Device
    • Biometric System
    • Exoskeletons
    • Intelligent Virtual Assistants
    • Virtual Reality Device
    • Wearable Device
  • Functionality
    • Body Worn
    • Non-Body Worn
  • End-use
    • Aerospace & Defense
    • Healthcare
    • Manufacturing
    • Media & Entertainment
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Human Augmentation Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Human Augmentation Market?

3. What are the technology trends and regulatory frameworks in the Human Augmentation Market?

4. What is the market share of the leading vendors in the Human Augmentation Market?

5. Which modes and strategic moves are suitable for entering the Human Augmentation Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing awareness and acceptance of cognitive and physical enhancement applications
      • 5.1.1.2. Rising need for human augmentation for medical wearable devices
      • 5.1.1.3. Increasing demand from aerospace & defense for gesture-tracking purposes
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of development of human augmentation technologies
    • 5.1.3. Opportunities
      • 5.1.3.1. Continuous introduction of technologically advanced human augmentation
      • 5.1.3.2. Government support and private investments for advancing human augmentation technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Risk of data and identity breach with the usage of human augmentation technologies
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Expanding usage of augmented reality devices to provide hands-free data access and navigation guidance
    • 5.2.2. Functionality: Increasing usage of body-worn human augmentation to enhance mobility and endurance
    • 5.2.3. End-user: Increasing application of human augmentation technologies in the manufacturing sector to improve worker productivity and efficiency
  • 5.3. Market Trend Analysis
    • 5.3.1. Increasing deployment of human augmentation products across military and defense of the Americas
    • 5.3.2. Emphasis on R&D for development of breakthrough human augmentation technologies in the APAC region
    • 5.3.3. Substantial investments to develop innovative human augmentation technologies and expanding applications in aerospace & defense sector in the EMEA region
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework Analysis

6. Human Augmentation Market, by Type

  • 6.1. Introduction
  • 6.2. Augmented Reality Device
  • 6.3. Biometric System
  • 6.4. Exoskeletons
  • 6.5. Intelligent Virtual Assistants
  • 6.6. Virtual Reality Device
  • 6.7. Wearable Device

7. Human Augmentation Market, by Functionality

  • 7.1. Introduction
  • 7.2. Body Worn
  • 7.3. Non-Body Worn

8. Human Augmentation Market, by End-use

  • 8.1. Introduction
  • 8.2. Aerospace & Defense
  • 8.3. Healthcare
  • 8.4. Manufacturing
  • 8.5. Media & Entertainment

9. Americas Human Augmentation Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Human Augmentation Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Human Augmentation Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Google and Qualcomm Partner to Make RISC-V Chip for Wearable Devices
    • 12.3.2. Vuzix Enters into a Partnership Agreement with Quanta Computer
    • 12.3.3. Humane Officially Launches the AI Pin, its OpenAI-powered Wearable
    • 12.3.4. Enabling Human Connectivity: Phantom Neuro Merges Human Augmentation and IoT
    • 12.3.5. XoMotion Created by SFU Researchers to be World's most Advanced Exoskeleton for Mobility Challenged
    • 12.3.6. DuPont Collaborates with STMicroelectronics (ST) to Develop New Smart Wearable Device Concept for Monitoring Biosignals
    • 12.3.7. Wearable Company Oura Acquires Digital Identification Startup Proxy
    • 12.3.8. EUR 2 Million Funding for Novel Human Augmentation Innovations to Enhance Human Capability in Defense
    • 12.3.9. ARIA Research Receives USD 1.4 Million in Grant Funding to Build Human Augmentation Laboratory in Sydney
    • 12.3.10. Ekso Bionics Announces Acquisition of Human Motion and Control Business Unit Including Indego Product Line from Parker Hannifin Corporation
    • 12.3.11. KYOCERA Introduces New Human Augmentation Technology Prototypes in Japan with Advanced AI to Enhance Human Abilities
    • 12.3.12. Dasa Launches New Innovation Focus Area: Human Augmentation (HA)
    • 12.3.13. A Parisian Startup just Raised USD 45 Million to Build Human Exoskeletons

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. HUMAN AUGMENTATION MARKET RESEARCH PROCESS
  • FIGURE 2. HUMAN AUGMENTATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HUMAN AUGMENTATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. HUMAN AUGMENTATION MARKET DYNAMICS
  • FIGURE 7. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES HUMAN AUGMENTATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES HUMAN AUGMENTATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. HUMAN AUGMENTATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. HUMAN AUGMENTATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HUMAN AUGMENTATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HUMAN AUGMENTATION MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL HUMAN AUGMENTATION MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY AUGMENTED REALITY DEVICE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY AUGMENTED REALITY DEVICE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY BIOMETRIC SYSTEM, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY BIOMETRIC SYSTEM, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY EXOSKELETONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY EXOSKELETONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY INTELLIGENT VIRTUAL ASSISTANTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY INTELLIGENT VIRTUAL ASSISTANTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY VIRTUAL REALITY DEVICE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY VIRTUAL REALITY DEVICE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY WEARABLE DEVICE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY WEARABLE DEVICE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY BODY WORN, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY BODY WORN, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY NON-BODY WORN, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY NON-BODY WORN, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY AEROSPACE & DEFENSE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY AEROSPACE & DEFENSE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY HEALTHCARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY HEALTHCARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY MANUFACTURING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY MANUFACTURING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY MEDIA & ENTERTAINMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY MEDIA & ENTERTAINMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. AMERICAS HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 38. AMERICAS HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 39. AMERICAS HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 40. AMERICAS HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 41. AMERICAS HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 42. AMERICAS HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 43. AMERICAS HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 44. AMERICAS HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 45. ARGENTINA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 46. ARGENTINA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 47. ARGENTINA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 48. ARGENTINA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 49. ARGENTINA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 50. ARGENTINA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 51. BRAZIL HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 52. BRAZIL HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 53. BRAZIL HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 54. BRAZIL HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 55. BRAZIL HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 56. BRAZIL HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 57. CANADA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 58. CANADA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 59. CANADA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 60. CANADA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 61. CANADA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 62. CANADA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 63. MEXICO HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 64. MEXICO HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 65. MEXICO HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 66. MEXICO HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 67. MEXICO HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 68. MEXICO HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 69. UNITED STATES HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 70. UNITED STATES HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 71. UNITED STATES HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 72. UNITED STATES HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 73. UNITED STATES HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 74. UNITED STATES HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 75. UNITED STATES HUMAN AUGMENTATION MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 76. UNITED STATES HUMAN AUGMENTATION MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 86. AUSTRALIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 88. AUSTRALIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 90. AUSTRALIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 91. CHINA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 92. CHINA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 93. CHINA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 94. CHINA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 95. CHINA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 96. CHINA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 97. INDIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 98. INDIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 99. INDIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 100. INDIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 101. INDIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 102. INDIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 103. INDONESIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 104. INDONESIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 105. INDONESIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 106. INDONESIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 107. INDONESIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 108. INDONESIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 109. JAPAN HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 110. JAPAN HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 111. JAPAN HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 112. JAPAN HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 113. JAPAN HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 114. JAPAN HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 115. MALAYSIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. MALAYSIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. MALAYSIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 118. MALAYSIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 119. MALAYSIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 120. MALAYSIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 122. PHILIPPINES HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 123. PHILIPPINES HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 124. PHILIPPINES HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 125. PHILIPPINES HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 126. PHILIPPINES HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 127. SINGAPORE HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 128. SINGAPORE HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 129. SINGAPORE HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 130. SINGAPORE HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 131. SINGAPORE HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 132. SINGAPORE HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 133. SOUTH KOREA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 134. SOUTH KOREA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 135. SOUTH KOREA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 136. SOUTH KOREA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 137. SOUTH KOREA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 138. SOUTH KOREA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 139. TAIWAN HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 140. TAIWAN HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 141. TAIWAN HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 142. TAIWAN HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 143. TAIWAN HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 144. TAIWAN HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 145. THAILAND HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 146. THAILAND HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 147. THAILAND HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 148. THAILAND HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 149. THAILAND HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 150. THAILAND HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 151. VIETNAM HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 152. VIETNAM HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 153. VIETNAM HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 154. VIETNAM HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 155. VIETNAM HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 156. VIETNAM HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 165. DENMARK HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 166. DENMARK HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 167. DENMARK HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 168. DENMARK HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 169. DENMARK HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 170. DENMARK HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 171. EGYPT HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 172. EGYPT HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 173. EGYPT HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 174. EGYPT HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 175. EGYPT HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 176. EGYPT HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 177. FINLAND HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 178. FINLAND HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 179. FINLAND HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 180. FINLAND HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 181. FINLAND HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 182. FINLAND HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 183. FRANCE HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 184. FRANCE HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 185. FRANCE HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 186. FRANCE HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 187. FRANCE HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 188. FRANCE HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 189. GERMANY HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 190. GERMANY HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 191. GERMANY HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 192. GERMANY HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 193. GERMANY HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 194. GERMANY HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 195. ISRAEL HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 196. ISRAEL HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 197. ISRAEL HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 198. ISRAEL HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 199. ISRAEL HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 200. ISRAEL HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 201. ITALY HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 202. ITALY HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 203. ITALY HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 204. ITALY HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 205. ITALY HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 206. ITALY HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 207. NETHERLANDS HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 208. NETHERLANDS HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 209. NETHERLANDS HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 210. NETHERLANDS HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 211. NETHERLANDS HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 212. NETHERLANDS HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 213. NIGERIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 214. NIGERIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 215. NIGERIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 216. NIGERIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 217. NIGERIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 218. NIGERIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 219. NORWAY HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 220. NORWAY HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 221. NORWAY HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 222. NORWAY HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 223. NORWAY HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 224. NORWAY HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 225. POLAND HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 226. POLAND HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 227. POLAND HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 228. POLAND HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 229. POLAND HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 230. POLAND HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 231. QATAR HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 232. QATAR HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 233. QATAR HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 234. QATAR HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 235. QATAR HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 236. QATAR HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 237. RUSSIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 238. RUSSIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 239. RUSSIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 240. RUSSIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 241. RUSSIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 242. RUSSIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 243. SAUDI ARABIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 244. SAUDI ARABIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 245. SAUDI ARABIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 246. SAUDI ARABIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 247. SAUDI ARABIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 248. SAUDI ARABIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 249. SOUTH AFRICA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 250. SOUTH AFRICA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 251. SOUTH AFRICA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 252. SOUTH AFRICA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 253. SOUTH AFRICA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 254. SOUTH AFRICA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 255. SPAIN HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 256. SPAIN HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 257. SPAIN HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 258. SPAIN HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 259. SPAIN HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 260. SPAIN HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 261. SWEDEN HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 262. SWEDEN HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 263. SWEDEN HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 264. SWEDEN HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 265. SWEDEN HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 266. SWEDEN HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 267. SWITZERLAND HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 268. SWITZERLAND HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 269. SWITZERLAND HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 270. SWITZERLAND HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 271. SWITZERLAND HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 272. SWITZERLAND HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 273. TURKEY HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 274. TURKEY HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 275. TURKEY HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 276. TURKEY HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 277. TURKEY HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 278. TURKEY HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 279. UNITED ARAB EMIRATES HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 280. UNITED ARAB EMIRATES HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 281. UNITED ARAB EMIRATES HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 282. UNITED ARAB EMIRATES HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 283. UNITED ARAB EMIRATES HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 284. UNITED ARAB EMIRATES HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 285. UNITED KINGDOM HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 286. UNITED KINGDOM HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 287. UNITED KINGDOM HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 288. UNITED KINGDOM HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 289. UNITED KINGDOM HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 290. UNITED KINGDOM HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 291. HUMAN AUGMENTATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 292. HUMAN AUGMENTATION MARKET, FPNV POSITIONING MATRIX, 2023